We are evaluating a new treatment combining HDM201 and Pazopanib for patients with advanced soft tissue sarcomas. The goal is to understand its clinical impact on those with P53 wild-type tumors.
Health conditions and diseases that the clinical trial is designed to study and treat.
Soft tissue sarcoma is a rare type of cancer that arises in the soft tissues of the body, such as muscles, fat, blood vessels, and nerves. When it is advanced or metastatic, it means the cancer has spread beyond its original site.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.